Jul. 2 at 6:51 PM
$EMBC https://www.linkedin.com/posts/piyush-l-08071173_as-the-glp-1-therapeutic-landscape-expands-activity-7331382114493300737-9Ujl?utm_source=share&utm_medium=member_ios&rcm=ACoAAF8uyZsBJ4KgRdzHO0a-goDvvWzFA3Mt4oA
Here’s the direct translation without adding anything:
This is important because Piyush works at Dr. Reddy’s Laboratories as a Global Quality SME for Medical Device Combination Products. His opinion carries weight because he is directly involved in combination drug-device products.
Here’s the direct translation without adding anything
This is important because Piyush works at Dr. Reddy’s Laboratories as a Global Quality SME for Medical Device Combination Products. His opinion carries weight because he is directly involved in combination drug-device products.There are several reasons why EMBC cannot independently announce contracts concluded with companies, including non-disclosure agreements, trade secrets, and other issues. This is specific to EMBC's business. 2nd quarter
